Literature DB >> 1887864

Alpha 1-antitrypsin is present within the primary granules of human polymorphonuclear leukocytes.

D Y Mason1, E M Cramer, J M Massé, R Crystal, J M Bassot, J Breton-Gorius.   

Abstract

Elastase is a potent proteolytic enzyme found within human neutrophil primary granules. Its major inhibitor in the serum is alpha 1-antitrypsin, a protein that is synthesized by hepatocytes but which has recently also been shown to be synthesized by circulating neutrophils. The authors have therefore carried out an immunocytochemical study at the light microscopic and ultrastructural level to determine the intracellular localization of alpha 1-antitrypsin. Double labeling with colloidal gold showed that alpha 1-antitrypsin is localized at the same site as neutrophil elastase, i.e., within primary granules. Secondary granules (detected by labeling for lactoferrin) were unstained for alpha 1-antitrypsin. Elastase and its major inhibitor therefore coexist within the same granule population within human neutrophils. Some difference in their intraorganelle distribution existed at the ultrastructural level (in that elastase tended to be localized at the periphery of the granules whereas alpha 1-antitrypsin was usually diffusely present in the matrix of the granules), but further studies are required to determine whether the two molecules are already complexed with each other within the neutrophil.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1887864      PMCID: PMC1886217     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Ultrastructural localization of cytochrome b in the membranes of resting and phagocytosing human granulocytes.

Authors:  A J Jesaitis; E S Buescher; D Harrison; M T Quinn; C A Parkos; S Livesey; J Linner
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages.

Authors:  D H Perlmutter; F S Cole; P Kilbridge; T H Rossing; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 3.  Elastase in tissue injury.

Authors:  A Janoff
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

4.  Human neutrophil granule heterogeneity: immunolocalization studies using cryofixed, dried and embedded specimens.

Authors:  S A Livesey; E S Buescher; G L Krannig; D S Harrison; J G Linner; R Chiovetti
Journal:  Scanning Microsc Suppl       Date:  1989

5.  Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold.

Authors:  E Cramer; K B Pryzwansky; J L Villeval; U Testa; J Breton-Gorius
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

6.  Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells.

Authors:  K A Pulford; W N Erber; J A Crick; I Olsson; K J Micklem; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

7.  Colocalization of elastase and myeloperoxidase in human blood and bone marrow neutrophils using a monoclonal antibody and immunogold.

Authors:  E M Cramer; J E Beesley; K A Pulford; J Breton-Gorius; D Y Mason
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

8.  Ultrastructural localization of lysozyme in human neutrophils by immunogold.

Authors:  E M Cramer; J Breton-Gorius
Journal:  J Leukoc Biol       Date:  1987-03       Impact factor: 4.962

Review 9.  Molecular basis of alpha-1-antitrypsin deficiency.

Authors:  M Brantly; T Nukiwa; R G Crystal
Journal:  Am J Med       Date:  1988-06-24       Impact factor: 4.965

10.  Characterization of the bioluminescent organelles in Gonyaulax polyedra (dinoflagellates) after fast-freeze fixation and antiluciferase immunogold staining.

Authors:  M T Nicolas; G Nicolas; C H Johnson; J M Bassot; J W Hastings
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

View more
  8 in total

1.  Proteinase 3-dependent caspase-3 cleavage modulates neutrophil death and inflammation.

Authors:  Fabien Loison; Haiyan Zhu; Kutay Karatepe; Anongnard Kasorn; Peng Liu; Keqiang Ye; Jiaxi Zhou; Shannan Cao; Haiyan Gong; Dieter E Jenne; Eileen Remold-O'Donnell; Yuanfu Xu; Hongbo R Luo
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 2.  Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants.

Authors:  Megan Meyer; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-17       Impact factor: 5.464

3.  Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines.

Authors:  Mila Ljujic; Sanja Mijatovic; Mirna Z Bulatovic; Marija Mojic; Danijela Maksimovic-Ivanic; Dragica Radojkovic; Aleksandra Topic
Journal:  Pathol Oncol Res       Date:  2016-09-12       Impact factor: 3.201

Review 4.  Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

5.  Differences in distribution and synthesis of the functional opponents alpha 1-proteinase inhibitor and neutrophil elastase in eukaryotic cells.

Authors:  E Davids; A Ogilvie
Journal:  Histochem Cell Biol       Date:  1995-09       Impact factor: 4.304

6.  The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytes.

Authors:  S Kaw; M Hecker; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation.

Authors:  V Witko-Sarsat; B Descamps-Latscha
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

Review 8.  The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.

Authors:  Sabina Janciauskiene; Sabine Wrenger; Stephan Immenschuh; Beata Olejnicka; Timm Greulich; Tobias Welte; Joanna Chorostowska-Wynimko
Journal:  Front Pharmacol       Date:  2018-04-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.